Search Within

Michael Morris

  1. "Biostatistics Service"
Formats
  1. Journal Article (55)
  2. Meeting Abstract (30)
  3. Review (2)
Groups
  1. Biostatistics Service (87)
  2. Department of Medicine (87)
  3. Epidemiology and Biostatistics (87)
  4. Genitourinary Oncology Service (87)
  5. Solid Tumor Oncology Division (87)
  6. Radiology, Department of (41)

More Groups

People
  1. Glenn Heller (54)
  2. Howard Scher (52)
  3. Steven Larson (29)
  4. Susan Slovin (22)
  5. Mithat Gonen (19)
  6. Dana Rathkopf (15)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (9)
  5. 2021 (7)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Clinical Cancer Research (9)
  3. Journal of Nuclear Medicine (6)
  4. Cancer (3)
  5. Clinical Genitourinary Cancer (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. American Association for Cancer Research (10)
  3. Society of Nuclear Medicine (6)
  4. Elsevier Science, Inc. (5)
  5. Oxford University Press (5)
  6. Elsevier BV (4)

More Publishers

Results (87)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Transforming patient-centered cancer care using telehealth: The MATCHES center
    Review

    Bange, E. M.; Daly, R. M.; Lipitz-Snyderman, A.; Kuperman, G.; Polubriaginof, F. C. G.; Liebertz, C.; Doshi, S. D.; Stevanovic, K.; Chan, K.; Bernal, C.; more...
    Journal of the National Cancer Institute - Monographs (2024)

    Fulltext@MSK | Save
  • PRESTO: A phase III, open-label study of intensification of androgen blockade in patients with high-risk biochemically relapsed castration-sensitive prostate cancer (AFT-19)
    Journal Article

    Aggarwal, R.; Heller, G.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T.; Appleman, L.; Weckstein, D.; Patnaik, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Telemedicine and cancer care: Barriers and strategies to optimize delivery
    Review

    Doshi, S. D.; Bange, E. M.; Daly, B.; Kuperman, G.; Panageas, K. S.; Morris, M. J.
    The Cancer Journal (2024)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Dooley, K.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in the phase 3 Alliance A031201 trial of metastatic castration resistant prostate cancer (mCRPC) treated with androgen receptor (AR)-targeted therapies
    Meeting Abstract

    Jensen, J. L.; Bobek, O.; Chan, I. C. C.; Hillman, D. W.; Heller, G.; Druley, T. E.; Morris, M. J.; Milowsky, M. I.; Beltran, H.; Bolton, K. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Randomized phase III study of enzalutamide compared with enzalutamide plus abiraterone for metastatic castration-resistant prostate cancer (Alliance A031201 trial)
    Journal Article

    Morris, M. J.; Heller, G.; Hillman, D. W.; Bobek, O.; Ryan, C.; Antonarakis, E. S.; Bryce, A. H.; Hahn, O.; Beltran, H.; Armstrong, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Farooki, A.; Morris, M. J.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Alliance A031902 (CASPAR): A randomized phase (ph) 3 trial of enzalutamide with rucaparib/placebo in first-line metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rao, A.; Heller, G.; Ryan, C. J.; VanderWeele, D. J.; Lewis, L. D.; Tan, A.; Watt, C.; Chen, R. C.; Kohli, M.; Barata, P. C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save